Description
Azilect (Rasagiline) Tablets 1 mg. №30
Ingredients:
Each tablet contains 1 mg of Rasagiline.
Mechanism of Action:
Rasagiline, the active ingredient in Azilect, is a selective irreversible MAO-B inhibitor. It works by increasing dopamine levels in the brain, which helps improve motor symptoms in Parkinson’s disease.
Pharmacological Properties:
Azilect (Rasagiline) exhibits its therapeutic effects by inhibiting the enzyme monoamine oxidase type B (MAO-B), leading to increased levels of dopamine in the brain. This mechanism contributes to the improvement of motor symptoms associated with Parkinson’s disease.
Indications for Use:
Azilect (Rasagiline) is indicated for the treatment of Parkinson’s disease. It is utilized to enhance the symptoms of the disease and potentially slow down its progression.
Contraindications:
Azilect should not be used in individuals taking meperidine or those with severe liver disease. Patients are advised to consult their healthcare provider before initiating treatment with Azilect.
Side Effects:
Common side effects of Azilect may include headache, joint pain, and indigestion. It is essential to monitor for any unusual symptoms and promptly report them to the healthcare provider.
Usage Instructions:
The recommended dosage of Azilect (Rasagiline) is 1 mg once daily. The tablet should be swallowed whole with a glass of water and can be administered with or without food. Patients must adhere to the instructions provided by their healthcare professional.
Benefits Compared to Analogues:
Azilect (Rasagiline) offers advantages over other medications by specifically targeting MAO-B, leading to improved motor symptoms and potentially reducing motor fluctuations and dyskinesia in Parkinson’s disease patients.
Suitable Patient Groups:
Azilect (Rasagiline) is suitable for adult patients diagnosed with Parkinson’s disease. Dosage adjustments may be necessary for specific patient populations, such as the elderly, based on individual health considerations.
Storage Conditions and Shelf Life:
Azilect should be stored at room temperature, away from moisture and light. The shelf life of the product is as indicated on the packaging. Ensure proper storage to maintain the medication’s efficacy.
Packaging Description:
Azilect is available in packs containing 30 tablets, with each tablet encapsulating 1 mg of Rasagiline. The packaging is designed to protect the tablets from environmental factors and maintain their integrity.
Clinical Evidence and Proven Effectiveness:
Research published in the Journal of Neural Transmission has demonstrated the efficacy of Rasagiline in enhancing motor function and reducing disability in Parkinson’s disease patients. The study emphasized the long-term benefits of Rasagiline therapy in managing the symptoms of the disease.
